Safety, Tolerability, Pharmacokinetics and Efficacy of 180 mg Subcutaneous Risperidone From 6 mg Oral Risperidone
Condition: Schizophrenia Interventions: Drug: PERSERIS; Drug: Risperidone Sponsor: Indivior Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 7, 2019 Category: Research Source Type: clinical trials
